Your browser doesn't support javascript.
loading
Current statin use for patients with atherosclerotic cardiovascular disease in 39 large Chinese hospitals / 中华心血管病杂志
Chinese Journal of Cardiology ; (12): 397-401, 2011.
Artículo en Chino | WPRIM | ID: wpr-272235
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals.</p><p><b>METHODS</b>Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39 highest-ranking hospitals in 10 Chinese cities.</p><p><b>RESULTS</b>Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022) patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%, among patients with coronary heart disease without ischemic stroke was 59.2%.</p><p><b>CONCLUSION</b>Statin is underused in secondary prevention among patients with atherosclerotic CVD in China. There is a large gap between guideline recommended statin use and in practice. Thus, it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.</p>
Asunto(s)
Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Arteriosclerosis / Enfermedades Cardiovasculares / Trastornos Cerebrovasculares / China / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Usos Terapéuticos / Quimioterapia / Utilización de Medicamentos / Prevención Secundaria / Hospitales Tipo de estudio: Guía de Práctica Clínica Límite: Anciano / Femenino / Humanos / Masculino País/Región como asunto: Asia Idioma: Chino Revista: Chinese Journal of Cardiology Año: 2011 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Arteriosclerosis / Enfermedades Cardiovasculares / Trastornos Cerebrovasculares / China / Inhibidores de Hidroximetilglutaril-CoA Reductasas / Usos Terapéuticos / Quimioterapia / Utilización de Medicamentos / Prevención Secundaria / Hospitales Tipo de estudio: Guía de Práctica Clínica Límite: Anciano / Femenino / Humanos / Masculino País/Región como asunto: Asia Idioma: Chino Revista: Chinese Journal of Cardiology Año: 2011 Tipo del documento: Artículo